Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Sep-30-21 | Sep-30-20 | Sep-30-19 | Jun-30-19 | Mar-31-19 | Sep-30-18 | Jun-30-18 | Mar-31-18 |
| | 10-K | 10-K | 10-K | 8-K | 8-K | 10-K | 8-K | 8-K |
| Revenues: |
| Patient Support Systems | 1,568.3 | 1,539.1 | 1,490.5 | | | 1,429.5 | | |
| Front Line Care | 1,117.0 | 1,025.0 | 978.1 | | | 960.2 | | |
| Surgical Solutions | 333.4 | 316.9 | 438.7 | | | 458.3 | | |
| Total revenues | 3,018.7 | 2,881.0 | 2,907.3 | 2,124.5 | 1,397.7 | 2,848.0 | 2,088.8 | 1,380.2 |
| Revenue growth [+] | 4.8% | -0.9% | 2.1% | 1.7% | 1.3% | 3.8% | | |
| Patient Support Systems | 1.9% | 3.3% | 4.3% | | | 0.4% | | |
| Front Line Care | 9.0% | 4.8% | 1.9% | | | 8.5% | | |
| Surgical Solutions | 5.2% | -27.8% | -4.3% | | | 5.5% | | |
| Cost of goods sold | 1,430.6 | 1,405.9 | 1,482.3 | 1,085.3 | 715.1 | 1,453.8 | 1,070.8 | 710.2 |
| Gross profit | 1,588.1 | 1,475.1 | 1,425.0 | 1,039.2 | 682.6 | 1,394.2 | 1,018.0 | 670.0 |
| Gross margin | 52.6% | 51.2% | 49.0% | 48.9% | 48.8% | 49.0% | 48.7% | 48.5% |
| Selling, general and administrative | 887.0 | 820.4 | 941.0 | 695.6 | 449.2 | 891.6 | 676.3 | 454.4 |
| Research and development | 144.9 | 136.5 | 139.5 | 103.9 | 69.8 | 135.6 | 100.6 | 67.0 |
| Equity in earnings | | | | | | | | |
| Other operating expenses | 108.6 | 109.0 | | 17.7 | 11.5 | | 64.4 | 50.4 |
| EBITDA [+] | 633.4 | 588.0 | 539.3 | | | 563.5 | | |
| EBITDA growth | 7.7% | 9.0% | -4.3% | 25.6% | 54.9% | 9.2% | | |
| EBITDA margin | 21.0% | 20.4% | 18.5% | 10.4% | 10.9% | 19.8% | 8.5% | 7.1% |
| Depreciation | 62.8 | 60.6 | 62.1 | | | 78.6 | | |
| EBITA | 570.6 | 527.4 | 477.2 | 222.0 | 152.1 | 484.9 | 176.7 | 98.2 |
| EBITA margin | 18.9% | 18.3% | 16.4% | 10.4% | 10.9% | 17.0% | 8.5% | 7.1% |
| Amortization of intangibles | 123.0 | 118.2 | 132.7 | | | 117.9 | | |
| EBIT [+] | 447.6 | 409.2 | 344.5 | 222.0 | 152.1 | 367.0 | 176.7 | 98.2 |
| EBIT growth | 9.4% | 18.8% | -6.1% | 25.6% | 54.9% | 17.5% | | |
| EBIT margin | 14.8% | 14.2% | 11.8% | 10.4% | 10.9% | 12.9% | 8.5% | 7.1% |
| Non-recurring items [+] | 47.4 | 41.5 | 28.4 | | | 77.6 | | |
| Unusual expense | 47.4 | 41.5 | 28.4 | | | 77.6 | | |
| Interest expense | 65.6 | 74.0 | 89.6 | | | 95.0 | | |
| Interest expense | 65.6 | 74.0 | 89.6 | | | 95.0 | | |
| Other income (expense), net [+] | -31.8 | -22.5 | -17.9 | -66.0 | -41.8 | 2.8 | -68.9 | -45.9 |
| Gain (loss) on debt retirement | -9.8 | -15.6 | -3.0 | | | | | |
| Other | -22.0 | -6.9 | -14.6 | | | 2.8 | | |
| Pre-tax income | 302.8 | 271.2 | 208.6 | 156.0 | 110.3 | 197.2 | 107.8 | 52.3 |
| Income taxes | 54.3 | 48.2 | 56.4 | 31.7 | 18.6 | -55.2 | -54.2 | -64.5 |
| Tax rate | 17.9% | 17.8% | 27.0% | 20.3% | 16.9% | | | |
| Minority interest | | | | | | -7.4 | | |
| Net income | 248.5 | 223.0 | 152.2 | 124.3 | 91.7 | 259.8 | 162.0 | 116.8 |
| Net margin | 8.2% | 7.7% | 5.2% | 5.9% | 6.6% | 9.1% | 7.8% | 8.5% |
| |
| Basic EPS [+] | $3.75 | $3.35 | $2.28 | $1.84 | $1.36 | $3.92 | $2.40 | $1.73 |
| Growth | 12.2% | 46.8% | -41.9% | -23.2% | -21.5% | 92.6% | | |
| Diluted EPS [+] | $3.72 | $3.32 | $2.25 | $1.84 | $1.36 | $3.84 | $2.40 | $1.73 |
| Growth | 12.0% | 47.5% | -41.5% | -23.2% | -21.5% | 93.3% | | |
| |
| Dividends per share [+] | $0.94 | $0.87 | $0.83 | $620,000.00 | $410,000.00 | $0.78 | $580,000.00 | $380,000.00 |
| Growth | 7.6% | 4.9% | 6.1% | 6.9% | 7.9% | 10.1% | | |
| |
| Shares outstanding (basic) [+] | 66.2 | 66.6 | 66.8 | 67.5 | 67.5 | 66.2 | 67.6 | 67.5 |
| Growth | -0.6% | -0.2% | 0.8% | -0.1% | 0.0% | 1.0% | | |
| Shares outstanding (diluted) [+] | 66.8 | 67.2 | 67.7 | 67.5 | 67.5 | 67.6 | 67.6 | 67.5 |
| Growth | -0.5% | -0.7% | 0.1% | -0.1% | 0.0% | 0.6% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|